This is the last thing Europe needs, CBD controlled by the existing pharma players. It will stifle innovation and bump up prices .

The Future Of Europe’s CBD Market Lies With Big Pharma And OTC Pathway

Executive Summary

The “shakers and movers” in the European cannabidiol market in the next two to three years will be big pharma, says Irish synthetic CBD specialist Chanelle McCoy Health. With its purported health benefits, CBD will also need to go the way of OTC drugs, with medicinal claims supported by clinical trials, the firm predicts.

More info (paywall)